XY0206

· Shijiazhuang Yiling Pharmaceutical Co. Ltd

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for XY0206, covering 2023-05-26 to 2025-09-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effect of XY0206 on the QTc Interval in Chinese Healthy Participants [Phase 1]